1Conroy RM , Pyrrha K, Fitzgerald AP, et al. Estimation of ten yearrisk of fatal cardiovascular disease in Europe:the SCORE project [ J ]. Eur Heart J, 2003 (24) : 987-1003.
2McCMland RL, Chung H, Detrano R, et al.D istribu t/an of coronary artery calcium by race, gend er, and age:resu Its from theMu It iE thn ic Study ofA therosclerosis (MESA) [ J ]. Circulation , 2006 , 113 ( 1 ) : 3037.
6Lerman A, Sopko G. Woman and cardiovascular hear disease: clinical implications from the womens ischemia syndrome e- valuation study:are we smarter[J].J Am Coll Cardiol, 2006,47 (3Suppl) : s59-s62.
7Flint AJ,Rexrode KM,Hu FB,et al.Body mass index, waist cirenmference, and risk of coronary heart disease : a prospective study among men and women I J]. Obes Res Clin Pract, 2010,4(3) : 171-181.
8Uddin SN, Begum F, Malik F, et al. Coronary artery disease inyoung patients:clinical review and risk factor analysis [J]. Mymcnsinsh Med J, 2003 , 12( 1 ) : 3-7.
9ACCORD Study Group, Cushman WC, Evans GW, et al. Ef- fects of intensiveblood-pressure control in type2 diabetes mel- litus[J].N Engl J Med,2010(362): 1575-1585.
7Bengmark S.Advanced glycation and lipoxidation end products-amplifiers of inflammation:the role of food[J].JPEN J Parenter Enteral Nutr,2007,31(5):430-440.
8Basta G,Schmidt AM,De Caterina R.Advanced glycation end products and vascular inflammation:implications for accelerated atherosclerosis in diabetes[J].Cardiovasc Res,2004,63(4):582-592.
9Aso Y,Inukai T,Tayama K,et al.Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes[J].Acta Diabetol,2000,37(2):87-92.
10Pradhan AD,Rifai N,Buring JE,et al.Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women[J].Am J Med,2007,120(8):720-727.
